Re-evaluating the treatment of nongonococcal urethritis: Emphasizing emerging pathogens - A randomized clinical trial

Clinical Infectious Diseases

Volumn 52, Issue 2, 2011, Pages 163-170

  Schwebke, J R ^a   Rompalo, A ^b   Taylor, S ^c   Sena A C ^d   Martin, D H ^c   Lopez, L M ^e   Lensing, S ^f   Lee, J Y ^f  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e FAMILY HEALTH INTERNATIONAL   (United States)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; PLACEBO; TINIDAZOLE;

ABDOMINAL PAIN; ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA GENITALIUM; NAUSEA; NONHUMAN; NONSPECIFIC URETHRITIS; PATHOGENESIS; PHASE 2 CLINICAL TRIAL; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TASTE DISORDER; TREATMENT DURATION; TREATMENT RESPONSE; TRICHOMONAS; TRICHOMONAS VAGINALIS; VOMITING;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTIPROTOZOAL AGENTS; AZITHROMYCIN; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DOUBLE-BLIND METHOD; DOXYCYCLINE; DRUG THERAPY, COMBINATION; HUMANS; MALE; MIDDLE AGED; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS; TINIDAZOLE; TREATMENT OUTCOME; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS; URETHRITIS; YOUNG ADULT;

EID: 79951848615     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciq074     Document Type: Article

References (26)

1. Holmes K, Handsfield H, Wang S, et al. Etiology of nongonococcal urethritis. N Engl J Med 1975;292:1199-1205.
2. Wong J, Hines P, Brasher M, Rogers G, Smith R, Schachter J. The etiology of nongonococcal urethritis in men attending a venereal disease clinic. Sex Transm Dis 1977;4:4-8.
3. Swartz S, Kraus S, Herrmann K, Stargel M, Brown W, Allen S. Diagnosis and etiology of nongonococcal urethritis. J Infect Dis 1978;138:445-53.
4. Stamm W, Hicks C, Martin D, et al. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. JAMA 1995;274:545-549.
5. Totten P, Schwartz MA, Sjostrom KE, Kenny GE, Handsfield HH. Association of Mycoplasma genitalium with nongonococcal urethritis in heterosexual men. J Infect Dis 2001;2003:269-276. (Pubitemid 32066029)
6. Schwebke JR, Hook EW III. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J Infect Dis 2003;188:465-8. (Pubitemid 36960659)
7. Falk L, Fredlund H, Jensen J. Tetracycline treatment does not eradicate Mycoplasma genitalium. Sex Transm Dis 2003;79:318-319. (Pubitemid 37026351)
8. Wallin J, Fosgren A. Tinidazole-a new preparation for T. vaginalis infections. II. Clinical evaluation of a treatment with a single dose. Br J Venereal Dis 1974;50:148-150.
9. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2006;55:35-37.
10. Viitanen J, Haataja H, Mannisto PT. Concentrations of metronidazole and tinidazole in male genital tissues. Antimicrob Agents Chemother 1985;28:812-814. (Pubitemid 16196920)
11. Schwebke J, Lawing L. Improved detection of Trichomonas vaginalis in males using DNA amplification. J Clin Microbiol 2002;40:3681-3683.
12. Taylor-Robinson D, Gilroy CB, Hay PE. Occurrence of Mycoplasma genitalium in different populations and its clinical significance. Clin Infect Dis 1993;17: S66-S68. (Pubitemid 23227109)
13. Mena L, Wang X, Mroczkowski T, Martin D. Mycoplasma genitalium infections in asymptomatic men and men with urethritis attending a sexually transmitted disease clinic in New Orleans. Clin Infect Dis 2003;35:1167-1173.
14. Hobbs M, Kazembe P, Reed A, Miller W, Nkata E. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Trans Dis 1999;26:381-387. (Pubitemid 29372769)
15. Yokoi S, Maeda S, Kubota Y, et al. The role of Mycoplasma genitalium and Ureaplasma urealyticum biovar 2 in postgonococcal urethrits. Clin Inf Dis 2007;45:966-971.
16. Bradshaw C, Tabrizi SN, Read TRH, Garland SM, Hopkins CA. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis 2006;193:336-345. (Pubitemid 43122332)
17. Wendel K, Erbelding EJ, Gaydos CA, Rompalo A. Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic. Sex Transm Dis 2003;79:151-153. (Pubitemid 36469623)
18. Jensen JS, Orsum R, Dohn B, Uldum S, Worm AM, Lind K. Mycoplasma genitalium: a cause of male urethritis? Genitourin Med 1993;69:265-269. (Pubitemid 23244015)
19. Horner P, Thomas B, Gilroy C. Role of Mycoplasma genitalium and Ureaplasma urealycticum in acute and chronic nongonococcal urethritis. Clin Infect Dis 2001;32:995-1003. (Pubitemid 32299633)
20. Mena L, Mroczkowski TF, Nsuami M, Martin DH. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis 2009;48:1649-1654.
21. Handsfield H, Alexander E, Wang S, Pederssen H, Holmes K. Differences in the therapeutic response of chlamydia-positive and chlamydianegative forms of nongonococcal urethritis. J Am Vener Dis Assoc 1976;2:5-9.
22. Bowie W, Alexander J, Stimson J, Floyd J, Holmes K. Therapy for nongonococcal urethritis: double-blind randomized comparison for two doses and two durations of minocycline. Ann Int Med 1981;95:306-131.
23. Price M, Zimba D, Hoffman IF, et al. Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial. Sex Transm Dis 2003;30:516-522. (Pubitemid 36667033)
24. Krieger J. Clinical manifestations of trichomoniasis in men. Ann Intern Med 1993;118:844.
25. Jensen J, Bradshaw CS, Tabrizi SN, Fairley CK, Hamasuna R. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 2008;47:1546-1553.
26. Bradshaw C, Chen MY, Farley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS ONE 2008;3: e3618.